Entasis Therapeutics Holdings Inc (ETTX)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2022-07-13 | 2022-07-11 | A Achat |
Former 10% Owner Actionnaire important |
7 598 814
+35.1%
2,2016 717 391 USD |
7 598 814 +35.1% | 2,20 | 16 717 391 USD | |
| 2022-07-13 | 2022-07-08 | A Achat |
Former 10% Owner Actionnaire important |
11 671 662
+116.7%
2,2025 677 656 USD |
11 671 662 +116.7% | 2,20 | 25 677 656 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
General Counsel Dirigeant |
3 759
-7.5%
3,1911 991 USD |
3 759 -7.5% | 3,19 | 11 991 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
See Remarks Dirigeant |
3 759
-7.5%
3,1911 991 USD |
3 759 -7.5% | 3,19 | 11 991 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
See Remarks Administrateur exécutif |
11 974
-7.5%
3,1938 197 USD |
11 974 -7.5% | 3,19 | 38 197 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
Chief Development Officer Dirigeant |
4 001
-8.0%
3,1912 763 USD |
4 001 -8.0% | 3,19 | 12 763 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
Chief Scientific Officer Dirigeant |
3 759
-5.2%
3,1911 991 USD |
3 759 -5.2% | 3,19 | 11 991 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
See Remarks Dirigeant |
3 759
-7.5%
3,1911 991 USD |
3 759 -7.5% | 3,19 | 11 991 USD | |
| 2021-10-20 | 2021-10-19 | V Vente |
Chief Medical Officer Dirigeant |
3 759
-7.5%
3,1911 991 USD |
3 759 -7.5% | 3,19 | 11 991 USD | |
| 2020-09-01 | 2020-09-01 | A Achat | Actionnaire important |
4 672 897
+33.4%
2,6812 499 999 USD |
4 672 897 +33.4% | 2,68 | 12 499 999 USD | |
| 2020-06-12 | 2020-06-11 | A Achat | Actionnaire important |
12 677 490
+958.6%
2,5031 693 725 USD |
12 677 490 +958.6% | 2,50 | 31 693 725 USD | |
| 2020-01-13 | 2020-01-09 | V Vente |
Frazier Life Sciences VIII, L.P. Actionnaire important |
50 000
-3.7%
5,00250 010 USD |
50 000 -3.7% | 5,00 | 250 010 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
Topper James N Administrateur non-exécutif Actionnaire important |
375 887
+38.6%
15,005 638 305 USD |
375 887 +38.6% | 15,00 | 5 638 305 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
Pivotal bioVenture Partners Fund I, L.P. Actionnaire important |
337 724
+40.1%
15,005 065 860 USD |
337 724 +40.1% | 15,00 | 5 065 860 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
Clarus Lifesciences III, L.P. Actionnaire important |
453 395
+38.8%
15,006 800 925 USD |
453 395 +38.8% | 15,00 | 6 800 925 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
Preston Heather Administrateur non-exécutif Actionnaire important |
337 724
+40.1%
15,005 065 860 USD |
337 724 +40.1% | 15,00 | 5 065 860 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
Sofinnova Venture Partners IX, L.P. Actionnaire important |
337 724
+40.1%
15,005 065 860 USD |
337 724 +40.1% | 15,00 | 5 065 860 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
TPG Group Holdings (SBS) Advisors, Inc. |
262 539
+34.6%
15,003 938 085 USD |
262 539 +34.6% | 15,00 | 3 938 085 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
ASTRAZENECA PLC Actionnaire important |
246 666
+12.9%
15,003 699 990 USD |
246 666 +12.9% | 15,00 | 3 699 990 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
Frazier Life Sciences VIII, L.P. Actionnaire important |
375 887
+38.6%
15,005 638 305 USD |
375 887 +38.6% | 15,00 | 5 638 305 USD | |
| 2018-10-02 | 2018-09-28 | A Achat |
GALAKATOS NICHOLAS Administrateur non-exécutif Actionnaire important |
453 395
+38.8%
15,006 800 925 USD |
453 395 +38.8% | 15,00 | 6 800 925 USD | |
| 2018-10-01 | 2018-09-28 | A Achat |
Novo Holdings A/S Actionnaire important |
1 089 835
+99.8%
15,0016 347 525 USD |
1 089 835 +99.8% | 15,00 | 16 347 525 USD |